Mirabella Financial Services’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
31,014
-84,920
-73% -$2.68M 0.11% 83
2026
Q1
$3.25M Buy
115,934
+102,608
+770% +$3.36M 0.31% 55
2025
Q4
$499K Buy
+13,326
New +$438K 0.05% 264
2023
Q1
Sell
-31,576
Closed -$1.74M 486
2022
Q4
$1.74M Buy
31,576
+8,474
+37% +$466K 0.16% 108
2022
Q3
$1.02M Buy
+23,102
New +$1.13M 0.11% 110
2022
Q1
Sell
-37,083
Closed -$1.58M 601
2021
Q4
$1.58M Buy
+37,083
New +$1.48M 0.16% 129
2020
Q4
Sell
-14,232
Closed -$482K 389
2020
Q3
$482K Buy
+14,232
New +$519K 0.07% 144

Other funds holding HRMY

Mirabella Financial Services's HRMY Position: Q2 2026 in Review

Mirabella Financial Services reduced its Harmony Biosciences (HRMY) stake by 73% in Q2 2026, selling an estimated $2.68M and leaving 31,014 shares worth $1.13M. The position accounts for 0.11% of the portfolio, ranked #83.

Mirabella Financial Services first reported a position in HRMY in Q3 2020 and has held it in 7 quarters since. The position peaked at $3.25M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mirabella Financial Services held 31,014 shares of Harmony Biosciences worth $1.13M as of Q2 2026.
  • Mirabella Financial Services sold 84,920 Harmony Biosciences shares in Q2 2026, an estimated $2.68M.
  • Harmony Biosciences made up 0.11% of Mirabella Financial Services's portfolio in Q2 2026, its #83 holding.
  • Mirabella Financial Services first reported a position in Harmony Biosciences in Q3 2020 and has held it in 7 quarters since.
  • Mirabella Financial Services's Harmony Biosciences position peaked at $3.25M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.